Mandate

Vinge advises Oral Care in connection with the acquisition of Dutch dental care provider De Tandartsengroep (DTG)

DTG operates 31 clinics and 8 dental laboratories in the Netherlands. Oral Care is a portfolio company of Axcel VI and operates a network of dental clinics in Sweden, Norway and the Netherlands. To support this expansion, Axcel VII is joining Axcel VI as a shareholder in Oral Care.

The transaction is subject to customary approval by the Dutch Health Care Authority and the Dutch Authority for Consumers and Markets (ACM).

Vinge's team consisted of Christina Kokko, Manon de Cooman, Gustav Wahlberg, Helena Liljenberg, Josef Groow (M&A), Alice Göransson (Employment Law), Avid Axelryd (Intellectual Property), Calle Tengwall Pagels, August Ahlin, Sara Jansson (Banking and Finance), Carla Håkansson, Katja Hägglund (Commercial Agreements), Frida Lansfjord, Jacob Guve, Alma Rotsman, Augus Olding (Assistants).

Read the client's press release here.

Related

Vinge advises Revivo Group on the acquisition of Premator

Revivo Group AB has acquired all the shares in Premator AB, the parent company of a group operating in the field of advanced surface treatment with extensive experience in shot blasting, anti-corrosion painting and related services. Operations are conducted in Sweden, Norway and Denmark.
September 03, 2026

Vinge advises the sellers of Berg Propulsion

Vinge has advised the sellers in connection with the sale of Berg Propulsion to Kongsberg Maritime.
September 03, 2026

Vinge advises the sellers on the sale of Nextory to Bonnier Books

Vinge has acted as legal adviser to the sellers in connection with Bonnier Books’ acquisition of Nextory, one of Europe’s leading streaming services for audiobooks and e-books. Bonnier Books is acquiring all shares in Nextory, and the transaction comprises Nextory’s operations in Sweden and internationally. The acquisition is a cash transaction and the parties have agreed not to disclose the purchase price. The transaction is subject to customary regulatory approvals.
September 02, 2026